339 related articles for article (PubMed ID: 35670121)
1. Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease.
Hsiao SW; Yen HH; Chen YY
Gut Liver; 2022 Nov; 16(6):840-848. PubMed ID: 35670121
[TBL] [Abstract][Full Text] [Related]
2. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
5. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
7. Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
Linson EA; Hanauer SB
Curr Gastroenterol Rep; 2021 Aug; 23(9):16. PubMed ID: 34338892
[TBL] [Abstract][Full Text] [Related]
8. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
9. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
Wijnands AM; Mahmoud R; Lutgens MWMD; Oldenburg B
Eur J Intern Med; 2021 Nov; 93():35-41. PubMed ID: 34481721
[TBL] [Abstract][Full Text] [Related]
10. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
[TBL] [Abstract][Full Text] [Related]
12. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid.
Bernstein CN; Eaden J; Steinhart AH; Munkholm P; Gordon PH
Inflamm Bowel Dis; 2002 Sep; 8(5):356-61. PubMed ID: 12479651
[TBL] [Abstract][Full Text] [Related]
13. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
14. [Recent Advances in Understanding Colorectal Cancer and Dysplasia Related to Ulcerative Colitis].
Yang DH
Korean J Gastroenterol; 2015 Dec; 66(6):312-9. PubMed ID: 26691188
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.
Mouzas IA; Papavassiliou E; Koutroubakis I
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):421-5. PubMed ID: 9789142
[TBL] [Abstract][Full Text] [Related]
17. Preventing neoplastic progression in ulcerative colitis.
Ullman TA
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S66-9. PubMed ID: 15758662
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
19. Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop.
Axelrad JE; Cross RK
Am J Gastroenterol; 2023 Mar; 118(3):429-431. PubMed ID: 36584365
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]